ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2023, Vol. 32 ›› Issue (3): 249-253.DOI: 10.3969/j.issn.1006-298X.2023.03.011

• • 上一篇    下一篇

嵌合抗原受体T细胞治疗自身免疫性疾病的研究进展

  

  • 出版日期:2023-06-28 发布日期:2023-07-01

Advances in chimeric antigen receptor T cells therapy for autoimmune diseases

  • Online:2023-06-28 Published:2023-07-01

摘要:

自身免疫性疾病是免疫系统无法识别自身抗原和组织并产生免疫应答导致自身组织器官损伤或功能异常的一类疾病。嵌合抗原受体T(CAR-T)细胞治疗被认为是有前景的新型肿瘤免疫治疗,其在B淋巴母细胞白血病等血液系统恶性肿瘤中取得了巨大成功,也为自身免疫性疾病的治疗提供了新思路。


关键词: 自身免疫病, 嵌合抗原受体T细胞免疫疗法, 细胞免疫疗法

Abstract: Autoimmune disease is a type of disease in which the immune system is unable to recognize autoantigens and tissues and produce immune response, resulting in damage or functional abnormalities of tissues and organs.Chimeric antigen receptor T cells (CAR-T) therapy is regarded as a promising new type of tumor immunotherapy, which has achieved great success in hematological malignancies such as B lymphoblastic leukemia, and also provides a new idea for the treatment of autoimmune diseases.

Key words: autoimmune disease, chimeric antigen receptor T cell immunotherapy, cellular immunotherapy